The Characteristics and Patterns of Drug-Resistant Pulmonary Tuberculosis in Eastern India.

The Characteristics and Patterns of Drug-Resistant Pulmonary Tuberculosis in Eastern India.
复制标题

DOI:
10.3390/tropicalmed7090244
复制
发表时间:
2022-09-13
影响因子:
2.9
通讯作者:
Kanodia S
Kanodia S
中科院分区:
医学3区
文献类型:
--
作者:
Giri VP;Giri OP;Pandey PT;Mishra KN;Prasad RS;Lal PK;Pratap R;Nikhil N;Sufian A;Ahmad R;Kanodia S

文献摘要

参考文献

被引文献

相似文献

背景:耐药结核病是世界各地的一个主要公共卫生问题,在印度也造成了很高的发病率和死亡率。早期诊断是结核病治疗的基石。国家层面和群体层面的耐药性变化是可能存在的,应不时定期检查。材料与方法:本前瞻性队列研究(2019年1月至2022年5月)在达尔班加医学院医院对耐药肺结核患者进行研究。痰标本从指定的中心采集。快速分子耐药试验(基因型试验)和基于生长的药敏试验(表型试验)在国家消除结核病规划认证的实验室进行。结果:共纳入268例耐药肺结核患者。治愈100例(37.31%);完成治疗43例(16.04%);死亡56例(20.89%);治疗失败22例(8.21%);随访失败34例(12.69%);转移出耐药肺结核13例(4.85%)。199例耐药肺结核患者出现不良事件,占74.25%。结论:耐药肺结核患者是一个值得关注和重视的问题。
Background: Drug-resistant tuberculosis is a major public health problem throughout the world and accounts for substantial morbidity and mortality rates in India, too. Early diagnosis is the corner stone of tuberculosis treatment. State-level and cluster-wise variations in drug resistance is a possibility and should be regularly checked in from time to time. Materials and Methods: The present prospective cohort study (January 2019 to May 2022) was conducted in Darbhanga Medical College and Hospital on drug-resistant pulmonary tuberculosis patients. Sputum specimens were collected from designated centers. Rapid molecular drug-resistance testing (genotypic tests) and growth-based drug-susceptibility testing (DST) (phenotypic tests) were performed in the National Tuberculosis Elimination Program certified Laboratory. Results: A total of 268 patients with drug-resistant pulmonary tuberculosis were included in the study group. The treatment outcomes revealed as cured in 100 (37.31%); treatment completed in 43 (16.04%); died in 56 (20.89%); treatment failed in 22 (8.21%); loss of follow up in 34 (12.69%); and transferred out in 13 (4.85%) drug-resistant pulmonary tuberculosis patients. Adverse events were recorded in 199 (74.25%) of the drug-resistant pulmonary tuberculosis patients. Conclusions: Drug-resistant pulmonary tuberculosis patients are a matter of concern and need to be addressed.
DOI: 10.1016/s1473-3099(21)00811-2
发表时间: 2022-07
影响因子: 56.3
作者:
Ndjeka, Norbert;Campbell, Jonathon R.;Meintjes, Graeme;Maartens, Gary;Schaaf, H. Simon;Hughes, Jennifer;Padanilam, Xavier;Reuter, Anja;Romero, Rodolfo;Ismail, Farzana;Enwerem, Martin;Ferreira, Hannetjie;Conradie, Francesca;Naidoo, Kogieleum;Menzies, Dick
通讯作者: Menzies, Dick
DOI: 10.1183/13993003.00387-2017
发表时间: 2017-05-01
影响因子: 24.3
作者:
Borisov, Sergey E.;Dheda, Keertan;Migliori, Giovanni Battista
通讯作者: Migliori, Giovanni Battista
DOI: 10.1515/jbcpp-2020-0468
发表时间: 2021-07-01
影响因子: --
作者:
Pratama, Novan Yusuf Indra;Zulkarnain, Bambang Subakti;Fatmawati, Umi
通讯作者: Fatmawati, Umi
DOI: 10.4046/trd.2021.0115
发表时间: 2021-10
影响因子: 2.9
作者:
Putra ON;Hidayatullah AYN
通讯作者: Hidayatullah AYN
DOI: 10.1016/s2213-2600(18)30235-2
发表时间: 2018-09-01
影响因子: 76.2
作者:
Schnippel, Kathryn;Ndjeka, Norbert;Conradie, Francesca
通讯作者: Conradie, Francesca